SLC5A2 and type 2 diabetes mellitus: About the effectiveness of SGLT2 inhibitors on different age interval, the SGLT2 inhibitors produced better therapeutic outcome in T2DM individuals younger than 40-year-old compared to their older counterpart which may result from the better urinary glucose excretion in the young group 36.